[Form 4] MEI Pharma, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lite Strategy, Inc. (LITS) director Lee Charles Benjamin received a non‑derivative grant of 10,000 stock options on 10/03/2025 with an exercise price of $2.56. The option is a stock option exercisable into 10,000 shares of common stock and expires on 10/03/2035. The grant vests in 36 equal monthly installments, with the first monthly installment vesting one month after the grant, subject to continued service through each vesting date. Following the reported transaction the reporting person is shown as beneficially owning the 10,000 underlying shares on a direct basis. The filing was submitted under power of attorney by Justin J. File and dated 10/06/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee Charles Benjamin

(Last) (First) (Middle)

9466 GEORGIA AVENUE #124

(Street)

SILVER SPRING, MD 20910

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ LITS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.56	10/03/2025		A		10,000		(1)	10/03/2035	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. Such option shall vest and become exercisable in 36 equal monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.

	/s/ Justin J. File, as Attorney-in-fact for the Reporting Person	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lite Strategy (LITS) director Lee Charles Benjamin receive on 10/03/2025?

He received a grant of 10,000 stock options exercisable into common stock at an exercise price of $2.56 with an expiration date of 10/03/2035.

How does the option vest for the LITS grant to Lee Charles Benjamin?

The option vests in 36 equal monthly installments, with the first installment vesting one month after the grant, subject to continued service.

How many shares does the option cover and how many are reported as beneficially owned after the transaction?

The option covers 10,000 underlying shares and 10,000 shares are reported as beneficially owned following the transaction.

Who signed the Form 4 filing for Lee Charles Benjamin and when was it filed?

The Form 4 was filed under power of attorney by Justin J. File and dated 10/06/2025.

What is the exercise price and expiration of the stock option granted to the LITS director?

The exercise price is $2.56 and the option expires on 10/03/2035.